West Pharmaceutical Servs Sees Q2 Sales $830.000M-$850.000M vs $818.537M Est

Benzinga Newsdesk www.benzinga.com Positive 75.7%

Neg 0% Neu 0% Pos 75.7%

West Pharmaceutical Servs (NYSE:WST) sees Q2 sales of $830.000 million-$850.000 million vs $818.537 million analyst estimate.